Brown & Brown
Brown & Brown's revenue rose 22.8% to $5.9 billion in fiscal 2025. Its net margin was 17.9%, down from 20.7% a year earlier. Free cash flow was $1.4 billion, up 26.6%. It paid out $293 million in dividends and buybacks, 21% of free cash flow. The diluted share count rose 10.2%.
Net margin is net income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share grew 14.8% a year and net income 17.0% a year, as new shares raised the share count by 14% and diluted each share's earnings.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Brown & Brown yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Brown & Brown's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Brown & Brown's fiscal 2025 free cash flow of $1.4B, net cash of −$6.5B at December 31, 2025 and 313 million diluted shares, from its filings. The scenarios are fitted to Brown & Brown: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 18.2% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 7% for a stable business (Insurance Brokers); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $71.08
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Brown & Brown's earnings per share of $3.16 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 22.5×, the middle of Brown & Brown's own P/E today, its peers' median and its sector's median (Brown & Brown's own P/E today) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 8%, 7% and 6%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $71.08
- Value at this multiple, against the last close
- —
- Brown & Brown's P/E at the last close
- 22.5×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| Arthur J. GallagherAJG | $266.79 | $6.03 | 44.2× |
| Brown & BrownBRO | $71.08 | $3.16 | 22.5× |
| Willis Towers WatsonWTW | $324.67 | $16.16 | 20.1× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 706 | 662 | 711 | 685 | 1,079 |
| Debt incl. finance leases | 2,023 | 3,942 | 3,796 | 3,824 | 7,613 |
| Net debt (negative means net cash) | 1,317 | 3,280 | 3,085 | 3,139 | 6,534 |
| Net debt to EBITDA | 1.5x | 3.1x | 2.2x | 2.0x | 3.8x |
| Debt to equity | 0.5x | 0.9x | 0.7x | 0.6x | 0.6x |
| Interest coverage | 12.7x | 7.2x | 7.0x | 7.8x | 5.6x |
| Current ratio | 1.2x | 1.1x | 1.0x | 1.1x | 1.0x |
| Quick ratio | 1.2x | 1.1x | 1.0x | 1.1x | 1.0x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 2 insiders bought $164,123 of Brown & Brown shares on the open market, and none sold any.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Joia M JohnsonDirector | Bought | 860 | $58.05 | $49,923 | Form 4 |
| May 5, 2026 | Proctor H Palmer JrDirector | Bought | 2,000 | $57.10 | $114,200 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Fail |
| Current ratio rose | Fail | Pass | Fail |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 4 of 8 | 7 of 8 | 4 of 8 |
| Accruals ratio | −1.0% | −1.1% | −1.7% |
Compare
Put Brown & Brown side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Brown & Brown | FY25 | 22.8% | — | 23.4% | 9.1% | 3.8x | 4 | |
| Erie Indemnity | FY25 | 7.2% | 17.6% | 14.0% | 31.8% | −0.5x | — | Compare |
| Willis Towers Watson | FY25 | −2.2% | 23.0% | 15.9% | 12.8% | 2.5x | 7 | Compare |
| Ryan Specialty | FY25 | 21.3% | 16.2% | 21.0% | 8.7% | 4.1x | — | Compare |
| Arthur J. Gallagher | FY25 | 20.7% | — | 12.8% | 9.9% | 3.3x | 3 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 1,767 | 1,881 | 2,014 | 2,392 | 2,613 | 3,051 | 3,573 | 4,257 | 4,805 | 5,902 |
| Revenue growth | 6.4% | 6.5% | 7.1% | 18.8% | 9.2% | 16.8% | 17.1% | 19.1% | 12.9% | 22.8% |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — | — | — |
| Net income | 258 | 400 | 344 | 398 | 480 | 587 | 672 | 871 | 993 | 1,054 |
| Diluted EPS (US$) | 0.91 | 1.40 | 1.22 | 1.40 | 1.69 | 2.07 | 2.37 | 3.05 | 3.46 | 3.16 |
| Diluted shares (millions) | 276 | 278 | 276 | 275 | 276 | 277 | 279 | 281 | 284 | 313 |
| Cash flow | ||||||||||
| Cash from operations | 411 | 442 | 568 | 678 | 713 | 809 | 881 | 1,010 | 1,174 | 1,450 |
| Capital expenditure | 18 | 24 | 42 | 73 | 71 | 45 | 52 | 69 | 82 | 68 |
| Free cash flow | 393 | 418 | 526 | 605 | 642 | 764 | 829 | 941 | 1,092 | 1,382 |
| Dividends paid | 70 | 78 | 85 | 91 | 101 | 107 | 120 | 135 | 154 | 193 |
| Share buybacks | 19 | 129 | 91 | 59 | 55 | 83 | 74 | 0 | 0 | 100 |
| Acquisitions | 123 | 42 | 924 | 353 | 695 | 367 | 1,928 | 631 | 890 | 7,854 |
| Stock-based compensation | 16 | 31 | 34 | 47 | 60 | 61 | 66 | 89 | 101 | 93 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 531 | 598 | 452 | 554 | 674 | 706 | 662 | 711 | 685 | 1,079 |
| Debt incl. finance leases | 1,074 | 976 | 1,507 | 1,555 | 2,096 | 2,023 | 3,942 | 3,796 | 3,824 | 7,613 |
| Total assets | 5,263 | 5,748 | 6,689 | 7,623 | 8,966 | 9,795 | 13,974 | 14,883 | 17,612 | 29,991 |
| Total liabilities | 2,902 | 3,165 | 3,688 | 4,272 | 5,212 | 5,598 | 9,368 | 9,304 | 11,175 | 17,418 |
| Shareholders' equity | 2,360 | 2,583 | 3,001 | 3,350 | 3,754 | 4,197 | 4,607 | 5,579 | 6,437 | 12,573 |
| Margins and ratios | ||||||||||
| Gross margin | — | — | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — | — | — |
| Net margin | 14.6% | 21.2% | 17.1% | 16.7% | 18.4% | 19.2% | 18.8% | 20.5% | 20.7% | 17.9% |
| Free cash flow margin | 22.3% | 22.2% | 26.1% | 25.3% | 24.6% | 25.0% | 23.2% | 22.1% | 22.7% | 23.4% |
| Return on capital | 9.8% | 14.8% | 10.7% | 10.6% | 11.0% | 11.9% | 11.7% | 12.3% | 12.6% | 9.1% |
| Return on equity | 11.4% | 16.2% | 12.3% | 12.6% | 13.5% | 14.8% | 15.3% | 17.1% | 16.5% | 11.1% |
| Return on assets | 5.0% | 7.3% | 5.5% | 5.6% | 5.8% | 6.3% | 5.7% | 6.0% | 6.1% | 4.4% |
| Net debt to EBITDA | 1.1x | 0.7x | 2.0x | 1.6x | 2.0x | 1.5x | 3.1x | 2.2x | 2.0x | 3.8x |